• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无功能性垂体腺瘤的发病机制。

Pathogenesis of non-functioning pituitary adenomas.

机构信息

Section of Endocrinology and Internal Medicine, Department of Medical Sciences, University of Ferrara, Via Ariosto 35, 44100, Ferrara, Italy.

出版信息

Pituitary. 2018 Apr;21(2):130-137. doi: 10.1007/s11102-018-0874-6.

DOI:10.1007/s11102-018-0874-6
PMID:29404893
Abstract

The pathogenesis of non functioning pituitary adenomas (NFPA) is a complex process involving several factors, from molecular to genetic and epigenetic modifications, where tumor suppressor genes, oncogenes, cell cycle derangements have been demonstrated to play an important role. MicroRNAs (miRNAs) have also been identified as possible players in NFPA tumorigenesis and pituitary stem cells have been investigated for their potential role in pituitary tumor initiation. However, a critical role for paracrine signalling has also been highlighted. This review focuses on the current knowledge on the involvement of these factors in NFPA pathogenesis.

摘要

无功能垂体腺瘤(NFPA)的发病机制是一个复杂的过程,涉及到从分子到遗传和表观遗传修饰的几个因素,其中已证明肿瘤抑制基因、癌基因、细胞周期紊乱在其中起着重要作用。MicroRNAs(miRNAs)也被认为是 NFPA 肿瘤发生的可能参与者,而垂体干细胞也因其在垂体肿瘤发生中的潜在作用而被研究。然而,旁分泌信号的关键作用也得到了强调。本文综述了这些因素在 NFPA 发病机制中的作用的最新知识。

相似文献

1
Pathogenesis of non-functioning pituitary adenomas.无功能性垂体腺瘤的发病机制。
Pituitary. 2018 Apr;21(2):130-137. doi: 10.1007/s11102-018-0874-6.
2
Pituitary adenoma pathogenesis: an update.垂体腺瘤发病机制的研究进展。
Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):322-7. doi: 10.1097/MED.0b013e328354b2e2.
3
circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1.环状 RNA circOMA1 通过靶向 TPT1 抑制无功能垂体腺瘤的肿瘤生长。
J Clin Endocrinol Metab. 2019 Jun 1;104(6):2419-2434. doi: 10.1210/jc.2018-01851.
4
Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.通过分析微小RNA表达谱鉴定无功能侵袭性垂体腺瘤的新型生物标志物。
Biochem Genet. 2017 Jun;55(3):253-267. doi: 10.1007/s10528-017-9794-9. Epub 2017 Mar 17.
5
MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.微小 RNA 谱表明散发性无功能垂体腺瘤中 TGFβ 通路下调。
Pituitary. 2011 Jun;14(2):112-24. doi: 10.1007/s11102-010-0268-x.
6
Molecular Mechanisms Underlying Pituitary Pathogenesis.垂体发病机制的分子机制
Biochem Genet. 2016 Apr;54(2):107-19. doi: 10.1007/s10528-015-9709-6. Epub 2015 Dec 30.
7
A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.一项关于临床无功能性垂体腺瘤的临床病理和免疫组化研究:单机构经验。
Neurol India. 2010 May-Jun;58(3):418-23. doi: 10.4103/0028-3886.66336.
8
Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.对G2/M转换基因表达的系统研究揭示了无功能垂体腺瘤中的细胞周期蛋白依赖性激酶25(CDC25)改变。
Pathol Oncol Res. 2017 Jul;23(3):633-641. doi: 10.1007/s12253-016-0163-5. Epub 2016 Dec 21.
9
MicroRNAs: Suggested role in pituitary adenoma pathogenesis.微小 RNA:在垂体腺瘤发病机制中的作用。
J Endocrinol Invest. 2013 Nov;36(10):889-95. doi: 10.1007/BF03346759.
10
Molecular pathology of pituitary adenomas.垂体腺瘤的分子病理学
J Neurooncol. 2001 Sep;54(2):111-9. doi: 10.1023/a:1012940929072.

引用本文的文献

1
Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors.非功能性垂体神经内分泌肿瘤的诊断和治疗的最新证据更新。
Endocrinol Metab (Seoul). 2023 Dec;38(6):631-654. doi: 10.3803/EnM.2023.1838. Epub 2023 Nov 15.
2
Expression and Clinical Significance of MDM2 in Non-Functioning PitNETs.无功能垂体腺瘤中 MDM2 的表达及临床意义。
Medicina (Kaunas). 2023 Feb 15;59(2):373. doi: 10.3390/medicina59020373.
3
Aggressive nonfunctioning pituitary neuroendocrine tumors.侵袭性无功能性垂体神经内分泌肿瘤。

本文引用的文献

1
Pituitary adenomas, stem cells, and cancer stem cells: what's new?垂体腺瘤、干细胞和癌症干细胞:有何新进展?
J Endocrinol Invest. 2018 Jul;41(7):745-753. doi: 10.1007/s40618-017-0803-y. Epub 2017 Dec 8.
2
Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma.干细胞衰老导致小儿颅咽管瘤小鼠模型中垂体瘤诱导作用减弱。
Nat Commun. 2017 Nov 28;8(1):1819. doi: 10.1038/s41467-017-01992-5.
3
mutations in Brazilian patients with sporadic pituitary adenomas: a single-center evaluation.
Brain Tumor Pathol. 2022 Oct;39(4):183-199. doi: 10.1007/s10014-022-00441-6. Epub 2022 Jun 20.
4
A Retrospective Trail Investigating Temozolomide Neoadjuvant Chemotherapy Combined with Radiotherapy in Low-Grade Pituitary Tumors.一项关于替莫唑胺新辅助化疗联合放疗用于低级别垂体瘤的回顾性研究。
J Oncol. 2022 Mar 25;2022:4618664. doi: 10.1155/2022/4618664. eCollection 2022.
5
[Update on mechanisms of pituitary tumorigenesis.].[垂体肿瘤发生机制的最新进展。]
Rev Fac Cien Med Univ Nac Cordoba. 2021 Dec 28;78(4):423-429. doi: 10.31053/1853.0605.v78.n4.29189.
6
Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches.肿瘤相关巨噬细胞:垂体腺瘤研究的新视野。
Front Endocrinol (Lausanne). 2021 Dec 2;12:785050. doi: 10.3389/fendo.2021.785050. eCollection 2021.
7
Insights into Mechanisms of Tumorigenesis in Neuroendocrine Neoplasms.神经内分泌肿瘤发生机制的研究进展。
Int J Mol Sci. 2021 Sep 25;22(19):10328. doi: 10.3390/ijms221910328.
8
Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features.无功能垂体瘤中生长抑素和多巴胺受体基因表达水平的定量分析及其与临床和分子侵袭性特征的关联
J Clin Med. 2020 Sep 22;9(9):3052. doi: 10.3390/jcm9093052.
9
A Rare Case of Recurrent Pituitary Collision Tumors.复发性垂体碰撞瘤1例罕见病例
J Endocr Soc. 2020 Jul 2;4(9):bvaa089. doi: 10.1210/jendso/bvaa089. eCollection 2020 Sep 1.
10
Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells.垂体腺瘤干细胞的实验证据和临床意义。
Front Endocrinol (Lausanne). 2020 Feb 20;11:54. doi: 10.3389/fendo.2020.00054. eCollection 2020.
巴西散发性垂体腺瘤患者的基因突变:单中心评估
Endocr Connect. 2017 Nov;6(8):914-925. doi: 10.1530/EC-17-0237. Epub 2017 Oct 26.
4
Notch system is differentially expressed and activated in pituitary adenomas of distinct histotype, tumor cell lines and normal pituitaries.Notch系统在不同组织学类型的垂体腺瘤、肿瘤细胞系及正常垂体中存在差异表达和激活。
Oncotarget. 2017 Jul 6;8(34):57072-57088. doi: 10.18632/oncotarget.19046. eCollection 2017 Aug 22.
5
Stem/progenitor cells in pituitary organ homeostasis and tumourigenesis.垂体器官稳态与肿瘤发生中的干细胞/祖细胞
J Endocrinol. 2018 Jan;236(1):R1-R13. doi: 10.1530/JOE-17-0258. Epub 2017 Aug 30.
6
MEN4 and mutations: the latest of the MEN syndromes.MEN4 和 突变:MEN 综合征的最新类型。
Endocr Relat Cancer. 2017 Oct;24(10):T195-T208. doi: 10.1530/ERC-17-0243. Epub 2017 Aug 19.
7
Signal transducer and activator of transcription 3 (STAT3) promoter methylation and expression in pituitary adenoma.信号转导与转录激活因子3(STAT3)在垂体腺瘤中的启动子甲基化及表达情况
BMC Med Genet. 2017 Jul 14;18(1):72. doi: 10.1186/s12881-017-0434-3.
8
Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab.在接受伊匹单抗治疗的转移性黑色素瘤和前列腺癌患者队列中,垂体炎的发生率。
Endocrine. 2017 Dec;58(3):535-541. doi: 10.1007/s12020-017-1289-2. Epub 2017 Apr 12.
9
Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.通过分析微小RNA表达谱鉴定无功能侵袭性垂体腺瘤的新型生物标志物。
Biochem Genet. 2017 Jun;55(3):253-267. doi: 10.1007/s10528-017-9794-9. Epub 2017 Mar 17.
10
Microarray technology reveals potentially novel genes and pathways involved in non-functioning pituitary adenomas.微阵列技术揭示了与无功能垂体腺瘤相关的潜在新基因和途径。
Balkan J Med Genet. 2017 Mar 9;19(2):5-16. doi: 10.1515/bjmg-2016-0030. eCollection 2016 Dec 1.